4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-0113 |
| Compound Name: | 4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 408.43 |
| Molecular Formula: | C17 H20 N4 O6 S |
| Smiles: | Cc1nc(CN2C(COc3ccc(cc23)S(NCC2CCCO2)(=O)=O)=O)no1 |
| Stereo: | RACEMIC MIXTURE |
| logP: | 0.5828 |
| logD: | 0.5828 |
| logSw: | -2.5218 |
| Hydrogen bond acceptors count: | 12 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 106.648 |
| InChI Key: | YXYKAALZNFUDFK-GFCCVEGCSA-N |